Patent details

Basic Information

Publication number:

EP2896609

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP151529278

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Crystalline fingolimod citrate for the treatment of relapsing-remitting multiple sclerosis

French Title of Invention:

Citrate de fingolimod crystallin pour le traitement de la sclérose en plaques récurrente-rémittente

German Title of Invention:

Kristallines Fingolimod-citrat zur Behandlung von schubförmig auftretender Multipler Sklerose

SPC Number:

Dates

Filing date:

23/07/2010

Grant date:

27/06/2018

EP Publication Date:

22/07/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/06/2018

EP B1 Publication Date:

27/06/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/07/2018

Expiration date:

23/07/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/06/2018

 

 

Name:

ratiopharm GmbH

Address:

Graf-Arco-Strasse 3, 89079 Ulm, Germany (DE)

Inventor

1

Name:

Hiremath, Channaveerayya

Address:

India (IN)

2

Name:

Gidwani, Ramesh Matioram

Address:

India (IN)

Priority

Priority Number:

1535DE2009

Priority Date:

24/07/2009

Priority Country:

India (IN)

Classification

IPC classification:

C07C 59/265; C07C 215/28;

Publication

European Patent Bulletin

Issue number:

201826

Publication date:

27/06/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/11/2018	Outgoing Correspondence	1